Depression Medicines | FDA - U.S. Food and Drug Administration
Use the following information to help you talk to your healthcare provider about medicines called antidepressants that can help treat depression. The medicine charts list FDA-approved products...
FDA approves first-of-its-kind nasal spray for severe depression
Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD, and ...
FDA Approves Nasal Spray for Depression - Newsweek
1 day ago · The FDA has now expanded its approval to include the standalone use of the nasal spray for adults with treatment-resistant major depressive disorder. A stock photo showing a woman's face in shadow.
Depression | FDA - U.S. Food and Drug Administration
Jul 10, 2024 · To be diagnosed with depression, symptoms must be present nearly every day for at least two weeks. Symptoms vary from person to person and may include physical aches and pains. Some common...
FDA approves standalone use of J&J’s ketamine-derived depression ...
1 day ago · The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression, the ...
J&J's ketamine-derived nasal spray approved by FDA to treat depression
1 day ago · The Food and Drug Administration (FDA) approved Johnson & Johnson's ketamine-derived nasal spray to help millions of U.S. patients suffering from severe depression. Spravato, approved as a ...
FDA allows standalone use of nasal spray antidepressant Spravato ...
1 day ago · The FDA says esketamine, an antidepressant derived from the anesthetic and party drug ketamine, can now be prescribed on its own. It was approved in 2019 to treat severe depression.
FDA approves Spravato, first monotherapy nasal spray to treat depression
2 days ago · The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato was approved to treat a major depressive ...
Main ingredient in new nose spray for depression might shock …
1 day ago · NEW YORK – The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday.Spravato is a first-of-its-kind medication to help manage ...
FDA clears first digital treatment for depression, but experts ... - CNN
Apr 2, 2024 · The US Food and Drug Administration is allowing the use of Rejoyn, the first prescription digital treatment for major depressive disorder.